Rapid Micro Biosystems specializes in the development and deployment of advanced technologies for the rapid detection of microbial contamination in various industries, including pharmaceuticals, biologics, and medical devices. Its flagship product, Growth Direct™, revolutionizes quality control microbiological testing by automating processes traditionally reliant on time-consuming manual methods, thereby ensuring data integrity and compliance while enhancing operational efficiency. The company’s mission is to support its clients in achieving higher reliability and safety standards through innovative solutions, ultimately leading to improved patient outcomes. Headquartered in Lexington, Massachusetts, with additional facilities in Lowell, Germany, Switzerland, and Singapore, Rapid Micro Biosystems fosters a collaborative and inclusive work environment, offering opportunities for professional growth across diverse teams in fields such as microbiology, robotics, and AI.